VANCOUVER and HOUSTON, July 15, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ: EPIX; TSX-V: EPI), a pharmaceutical company focused on the developing novel therapies for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results